The Effect of Ciprofloxacin on the Pharmacokinetic and ECG Parameters of Quinidine
dc.contributor.author | Bleske, Barry E. | en_US |
dc.contributor.author | Carver, Peggy L. | en_US |
dc.contributor.author | Annesley, Thomas M. | en_US |
dc.contributor.author | Bleske, Jane R. M. | en_US |
dc.contributor.author | Morady, Fred | en_US |
dc.date.accessioned | 2013-04-08T20:49:34Z | |
dc.date.available | 2013-04-08T20:49:34Z | |
dc.date.issued | 1990-10 | en_US |
dc.identifier.citation | Bleske, Barry E.; Carver, Peggy L.; Annesley, Thomas M.; Bleske, Jane R. M.; Morady, Fred (1990). "The Effect of Ciprofloxacin on the Pharmacokinetic and ECG Parameters of Quinidine." The Journal of Clinical Pharmacology 30(10). <http://hdl.handle.net/2027.42/97168> | en_US |
dc.identifier.issn | 0091-2700 | en_US |
dc.identifier.issn | 1552-4604 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/97168 | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | The Effect of Ciprofloxacin on the Pharmacokinetic and ECG Parameters of Quinidine | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, College of Pharmacy | en_US |
dc.contributor.affiliationum | University of Michigan Medical Center Departments of Pharmacy | en_US |
dc.contributor.affiliationother | Internal Medicine | en_US |
dc.contributor.affiliationother | Pathology | en_US |
dc.identifier.pmid | 2229451 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/97168/1/j.1552-4604.1990.tb03570.x.pdf | |
dc.identifier.doi | 10.1002/j.1552-4604.1990.tb03570.x | en_US |
dc.identifier.source | The Journal of Clinical Pharmacology | en_US |
dc.identifier.citedreference | Tartaglione TA, Raffalovich AC, Poynor WJ, Espinel‐Ingroff A, Kerkering TM: Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses. Antimicrob Agents Chemother 1986; 29: 62 – 66. | en_US |
dc.identifier.citedreference | Gau W, Kurz J, Petersen U, Ploschke HJ, Wuensche C: Isolation and structural elucidation of urinary metabolites of ciprofloxacin. Arzneim-Forsch/Drug Res 1986; 36 ( II ): 1545 – 1549. | en_US |
dc.identifier.citedreference | Wijnands WJA, Vree TB, van Herwaarden CLA: The influence of quinolone derivatives on theophylline clearance. Br J Clin Pharmacol 1986; 22: 677 – 683. | en_US |
dc.identifier.citedreference | Nix DE, DeVito JM, Whitbread MA, Schentag JJ: Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. J Antimicrob Chemother 1987; 19: 263 – 269. | en_US |
dc.identifier.citedreference | Prince RA, Casabar E, Adair CG, Wexler DB, Lettieri J, Kasik JE: Effect of quinolone antimicrobials on theophylline pharmacokinetics. J Clin Pharmacol 1989; 29: 650 – 654. | en_US |
dc.identifier.citedreference | Ludwig E, Szekely E, Csiba A, Graber H: The effect of ciprofloxacin on antipyrine metabolism. J Antimicrob Chemother 1988; 22: 61 – 67. | en_US |
dc.identifier.citedreference | Healy DP, Polk RE, Kanawati L, Rock DT, Mooney ML: Interaction between oral ciprofloxacin and caffeine in normal volunteers. Antimicrob Agents Chemother 1989; 33: 474 – 478. | en_US |
dc.identifier.citedreference | Drayer DE, Lowenthal DT, Restivo KM, Schwartz A, Cook CE, Reidenberg MM: Steady‐state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. Clin Pharmacol Ther 1978; 24: 31 – 39. | en_US |
dc.identifier.citedreference | Ueda CT: Quinidine, In Evans WE, Schentag JJ, Jusko WJ, (Eds.): Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. Spokane, Applied Therapeutics, Inc., 1986; 000 – 000. | en_US |
dc.identifier.citedreference | Hardy BG, Zador IT, Golden L, Lalka D, Schentag JJ: Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine. Am J Cardiol 1983; 52: 172 – 175. | en_US |
dc.identifier.citedreference | Kessler KM, Humphries WC, Black M, Spann JF: Quinidine pharmacokinetics in patients with cirrhosis or receiving propranolol. Am Heart J 1978; 96: 627 – 635. | en_US |
dc.identifier.citedreference | Edwards DJ, Lavoie R, Beckman H, Blevins R, Rubenfire M: The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine. Clin Pharmacol Ther 1987; 41: 68 – 73. | en_US |
dc.identifier.citedreference | Greenblatt DJ, Franke K, Huffman DH: Impairment of antipyrine clearance in humans by propranolol. Circulation 1978; 57: 1161 – 1164. | en_US |
dc.identifier.citedreference | Bax NDS, Lennard MS, Tucker GT: Inhibition of antipyrine metabolism by beta‐adrenoceptor antagonists. Br J Clin Pharmacol 1981; 12: 779 – 784. | en_US |
dc.identifier.citedreference | Bach DR, Blevins R, Kerner N, Rubenfire M, Edwards DJ: The effect of verapamil on antipyrine pharmacokinetics and metabolism in man. Br J Clin Pharmacol 1986; 21: 655 – 659. | en_US |
dc.identifier.citedreference | Wolf‐Rogers JA, Smith CM, Vaughn K: Automated fluorescence polarization immunoassay for monitoring quinidine (abstr). Clin Chem 1984; 30: 1020. | en_US |
dc.identifier.citedreference | Chen BH, Taylor EH, Ackerman BH, Olsen K, Pappas AA: Effect of pH on free quinidine (letter). Drug Intell Clin Pharm 1988; 22: 826. | en_US |
dc.identifier.citedreference | Verme CN, Ludden TM, Harris SC: Effect of temperature on in vitro measurement of quinidine free fraction. Clin Pharm 1988; 7: 142 – 146. | en_US |
dc.identifier.citedreference | Hoffken G, Lode H, Prinzing C, Borner K, Koeppe P: Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985; 27: 375 – 379. | en_US |
dc.identifier.citedreference | Vesell ES: Commentary. The antipyrine test in clinical pharmacology: Conceptions and misconceptions. Clin Pharmacol Ther 1979; 26: 275 – 286. | en_US |
dc.identifier.citedreference | Guengerich FP, Muller‐Enoch D, Blair IA: Oxidation of quinidine by human liver cytochrome P‐450. Mol Pharmacol 1986; 30: 287 – 295. | en_US |
dc.identifier.citedreference | Waite NM, Edwards DJ, Arnott WS, Warbasse LH: Effects of ciprofloxacin on testosterone and Cortisol concentrations in healthy males. Antimicrob Agents Chemother 1989; 33: 1875 – 1877. | en_US |
dc.identifier.citedreference | Ho G, Tierney MG, Dales RE: Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline. Clin Pharmacol Ther 1988; 44: 35 – 38. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.